Investigation of Molecular Changes in RAS/RAF/MEK/MAPK Pathway in Serous Adenocarcinomas and Serous Borderline Tumors of Ovary

Objectives:To investigate MAP Kinase (p38), c-Fos, c-Jun and c-Myc; in RAS/RAF/MEK/MAPK pathway by immunohistochemically in high grade serous adenocarcinomas, serous borderline tumors and benign lesions of the ovary.Materials and Methods:Twelve serous borderline tumors, 41 high-grade serous carcinom...

Full description

Bibliographic Details
Published in:	Ankara Üniversitesi Tıp Fakültesi Mecmuası
Main Author:	Cevriye Cansız Ersöz
Format:	Article
Language:	English
Published:	Ankara University Press 2020-08-01
Subjects:	ovary serous tumors ras/raf/mek/mapk pathway
Online Access:	http://ankaratipfakultesimecmuasi.net/archives/archive-detail/article-preview/nvestigation-of-molecular-changes-in-ras-raf-mek-m/39748

Similar Items

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
by: Ufuk Degirmenci, et al.
Published: (2020-01-01)

Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway
by: Wang Y, et al.
Published: (2020-03-01)

Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation
by: Jingwen Liu, et al.
Published: (2025-08-01)

Global gene analysis identifying genes commonly regulated by the Ras/Raf/MEK and type I IFN pathways
by: Y. Komatsu, et al.
Published: (2015-06-01)

Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
by: Yanlin Song, et al.
Published: (2023-01-01)

CircRAPGEF5 acts as a modulator of RAS/RAF/MEK/ERK signaling during colorectal carcinogenesis
by: Zhipeng Yin, et al.
Published: (2024-08-01)

Cellular model of neuronal atrophy induced by DYNC1I1 deficiency reveals protective roles of RAS-RAF-MEK signaling
by: Zhi-Dong Liu, et al.
Published: (2016-08-01)

Geniposide alleviates lipopolysaccharide-caused apoptosis of murine kidney podocytes by activating Ras/Raf/MEK/ERK-mediated cell autophagy
by: Xia Li, et al.
Published: (2019-12-01)

A diaryl urea derivative, SMCl inhibits cell proliferation through the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma
by: Yue Fu, et al.
Published: (2025-07-01)

Dayuan Yin alleviates symptoms of HCoV-229E-induced pneumonia and modulates the Ras/Raf1/MEK/ERK pathway
by: Rui Li, et al.
Published: (2024-11-01)

Huanglian Jiedu decoction alleviates neurobehavioral damage in mice with chronic alcohol exposure through the RAS-RAF-MEK-ERK pathway
by: Yun Chen, et al.
Published: (2024-04-01)

Efficiency of B-RAF-/MEK-inhibitors in B-RAF mutated Ameloblastoma: Case report and review of literature
by: Reinhard Büttner, et al.
Published: (2023-12-01)

RETRACTED ARTICLE: Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells
by: Shaojun Wang, et al.
Published: (2019-11-01)

Crystal Structure Reveals the Full Ras–Raf Interface and Advances Mechanistic Understanding of Raf Activation
by: Trinity Cookis, et al.
Published: (2021-07-01)

Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation
by: Tarah Elizabeth Trebino, et al.
Published: (2023-12-01)

Ovarian endometriosis with borderline serous tumor: A rare occurrence
by: Safia Rana, et al.
Published: (2023-01-01)

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
by: Jimin Yuan, et al.
Published: (2020-08-01)

Mechanism of Inhibition of Inflammation in Osteoarthritis by Tougu Xiaotong Capsule via Regulating Ras-Raf-MEK1/2-ERK1/2 Signaling Pathway
by: Munan LIN, et al.
Published: (2021-06-01)

Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation
by: Madhuri Martin, et al.
Published: (2017-11-01)

Remote Continuous Microinjury-Triggered Cytokines Facilitate Severe Diabetic Foot Ulcer Healing via the Ras/Raf/MEK/ERK Pathway
by: Huang X, et al.
Published: (2025-02-01)

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
by: Ozge Tatli, et al.
Published: (2021-12-01)

Targeting RAF dimers in RAS mutant tumors: From biology to clinic
by: Huanhuan Yin, et al.
Published: (2024-05-01)

Molecular-genetic mechanisms of the signal cascade RAS-RAF-MEK-ERK associated with the development of the tumor process and the purpose of targeted drugs for colorectal cancer
by: A. N. Toropovsky, et al.
Published: (2021-08-01)

EC359 Enhances Trametinib Efficacy in <i>Ras</i>/<i>Raf</i>-Driven Ovarian Cancer by Suppressing LIFR Signaling
by: William C. Arnold, et al.
Published: (2025-09-01)

Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
by: Yahong Liu, et al.
Published: (2023-09-01)

Bilateral multifocal central serous retinopathy due to management of metastatic melanoma with BRAf MEK inhibitors: Case report
by: Grisma Patel, et al.
Published: (2023-03-01)

Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors
by: Jiawan Wang, et al.
Published: (2025-09-01)

Novel RAF‐directed approaches to overcome current clinical limits and block the RAS/RAF node
by: Rossella Scardaci, et al.
Published: (2024-06-01)

A Bioinformatic Analysis Predicts That Cannabidiol Could Function as a Potential Inhibitor of the MAPK Pathway in Colorectal Cancer
by: Julianne du Plessis, et al.
Published: (2024-08-01)

Ovarian endometriosis with borderline serous tumor- Association or coincidence – A case report and review of literature
by: Seema Dayal
Published: (2020-01-01)

Neuroendocrine Tumor of the Fallopian Tube and Serous Adenocarcinoma of the Ovary: Multicentric Primary Tumors
by: Nataliia HYRIAVENKO, et al.
Published: (2023-05-01)

Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways
by: Chaoyan Wang, et al.
Published: (2024-04-01)

Does Ras Activate Raf and PI3K Allosterically?
by: Ruth Nussinov, et al.
Published: (2019-11-01)

Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2
by: Helen Hoffmann, et al.
Published: (2023-10-01)

Renal sympathetic denervation attenuates left ventricle hypertrophy in spontaneously hypertensive rats by suppressing the Raf/MEK/ERK signaling pathway
by: Bing Xiao, et al.
Published: (2021-02-01)

An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation
by: Jeffrey J. Heard, et al.
Published: (2018-01-01)

Mechanisms of Ras Membrane Organization and Signaling: Ras Rocks Again
by: Daniel Abankwa, et al.
Published: (2020-11-01)

MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model
by: William E. Tidyman, et al.
Published: (2022-02-01)

Strong negative feedback from Erk to Raf confers robustness to MAPK signalling
by: Raphaela Fritsche‐Guenther, et al.
Published: (2011-05-01)

TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway
by: Yahui Tian, et al.
Published: (2024-07-01)